Podcasts

Introducing Congress Author Podcasts, a new podcast series where authors review their congress posters and presentations on cytokine signalling and JAK inhibitors. The first edition, recorded at ACR 2019 in Atlanta, focuses on upadacitinib.

Download the Posters Here

Professor Kevin Winthrop and Professor Leonard Calabrese present the key abstracts presented at this year\'s ACR conference in Atlanta.

Effect of Baricitinib and Adalimumab in Reducing Pain and Improving Function

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib

Comparison of Baricitinib, Upadacitinib, and Tofacitinib Mediated Regulation of Cytokine Signalling in Human Leukocyte Subpopulations...

Outcomes of Dose Reduction, Withdrawal, and Restart of Tofacitinib in Patients with Rheumatoid Arthritis: A Prospective Observational Study...

Safety and Effectiveness of Upadacitinib or Adalimumab Plus Methotrexate in Patients with Rheumatoid Arthritis Over 48 Weeks with Switch to Alternate Therapy in Patients with Insufficient Response....

Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase 3, Double-Blind, Randomized Controlled Trial....

Live Zoster Vaccine in Patients with Rheumatoid Arthritis Treated with Tofacitinib with or without Methotrexate, or Adalimumab with Methotrexate....